Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eve Merry

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Medicine (London, England)|April 9, 2019
Continuation of acid suppression therapy on intensive care discharge: a clinical auditLouise Rayner, Eve Merry
Targeted Oncology|November 15, 2025
Targeting DNA Damage Repair Pathways Beyond PARP InhibitionEve Merry, Charlie Gourley
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2015
Cutting edge: circulating plasmablasts induce the differentiation of human T follicular helper cells via IL-6 productionKonstantia-Maria Chavele, Eve Merry, Michael R Ehrenstein
NPJ Precision Oncology|March 6, 2021
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomasEve Merry, Khin Thway, Robin L Jones, et al.
Clinical Sarcoma Research|September 1, 2020
Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primaryEve Merry, Alannah Smrke, Kapil Halai, et al.
Molecular and Clinical Oncology|October 2, 2020
Effect of carboplatin when administered after dacarbazine failure: Clinical benefit of sequential therapyEve Merry, Maria Marples, Sarah Danson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 4, 2024
A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer populationEve Merry, Ronas Taner Kesmez, Tamara Yu, et al.
JCO Global Oncology|July 9, 2020
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare CancersAlannah Smrke, Eugenie Younger, Roger Wilson, et al.
Cancers|December 10, 2021
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London HospitalYien Ning Sophia Wong, Christopher C T Sng, Diego Ottaviani, et al.
Cancers|August 23, 2020
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 PandemicEugenie Younger, Alannah Smrke, Emma Lidington, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Medicine (London, England)|April 9, 2019
Continuation of acid suppression therapy on intensive care discharge: a clinical auditLouise Rayner, Eve Merry
Targeted Oncology|November 15, 2025
Targeting DNA Damage Repair Pathways Beyond PARP InhibitionEve Merry, Charlie Gourley
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2015
Cutting edge: circulating plasmablasts induce the differentiation of human T follicular helper cells via IL-6 productionKonstantia-Maria Chavele, Eve Merry, Michael R Ehrenstein
NPJ Precision Oncology|March 6, 2021
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomasEve Merry, Khin Thway, Robin L Jones, et al.
Clinical Sarcoma Research|September 1, 2020
Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primaryEve Merry, Alannah Smrke, Kapil Halai, et al.
Molecular and Clinical Oncology|October 2, 2020
Effect of carboplatin when administered after dacarbazine failure: Clinical benefit of sequential therapyEve Merry, Maria Marples, Sarah Danson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 4, 2024
A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer populationEve Merry, Ronas Taner Kesmez, Tamara Yu, et al.
JCO Global Oncology|July 9, 2020
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare CancersAlannah Smrke, Eugenie Younger, Roger Wilson, et al.
Cancers|December 10, 2021
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London HospitalYien Ning Sophia Wong, Christopher C T Sng, Diego Ottaviani, et al.
Cancers|August 23, 2020
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 PandemicEugenie Younger, Alannah Smrke, Emma Lidington, et al.
Pageof 2